NewGenIvf Group Limited - Class A Ordinary Shares (NIVF)
0.4535
-0.1075 (-19.16%)
NASDAQ · Last Trade: Apr 4th, 4:46 PM EDT
Detailed Quote
Previous Close
0.5610
Open
0.5390
Bid
0.4300
Ask
0.4311
Day's Range
0.4151 - 0.5390
52 Week Range
0.1085 - 3.280
Volume
2,713,941
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
5,349,895
Chart
About NewGenIvf Group Limited - Class A Ordinary Shares (NIVF)
NewGenIvf Group Limited is a biotechnology company focused on providing innovative solutions and services in the field of reproductive health and fertility. The company specializes in advanced in vitro fertilization (IVF) technologies and offers a range of services to assist individuals and couples in their journey to conceive. Through its state-of-the-art laboratories and clinical expertise, NewGenIvf Group is dedicated to improving patient outcomes and enhancing the overall experience of assisted reproduction, while also engaging in research and development to advance fertility treatments. Read More
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
NewGenIvf shares are trading higher on Thursday after the company announced it secured $5.2 million in funding in order to drive international expansion.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding their previously announced reverse merger transaction.
BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) and its completion of its acquisition of MicroSort Reproductive Technology.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, announced that it has entered into a strategic collaboration agreement with BOBCARE FERTILITY GROUP LLC (“BOBCARE”) to jointly develop fertility services in the Kyrgyzstan market.
BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
